Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,922,224 papers from all fields of science
Search
Sign In
Create Free Account
Meglitinide
Known as:
4-(2-(5-chloro-2-methoxybenzamido)ethyl)benzoic acid
, meglitinide [Chemical/Ingredient]
, meglitinides
A benzamide belonging to the meglitinide class of antidiabetic agents with hypoglycemic activity. Meglitinide represents the basic structure of the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Benzamides
Hypoglycemic Agents
Glinides [Chemical/Ingredient]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Cardiovascular safety of glucose‐lowering agents as add‐on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register
Nils Ekström
,
A. Svensson
,
+4 authors
S. Gudbjörnsdottir
Diabetes, obesity and metabolism
2016
Corpus ID: 42745450
To investigate the relative safety of various glucose‐lowering agents as add‐on medication to metformin in type 2 diabetes in an…
Expand
2007
2007
Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1.
N. Duffy
,
B. Green
,
+4 authors
P. Flatt
European Journal of Pharmacology
2007
Corpus ID: 22088326
2007
2007
Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes…
O. Ushakova
,
V. Sokolovskaya
,
+11 authors
N. Starkova
Clinical Therapeutics
2007
Corpus ID: 28545341
Review
2007
Review
2007
Emergency management of oral hypoglycemic drug toxicity.
A. Rowden
,
C. Fasano
Emergency medicine clinics of North America
2007
Corpus ID: 212118
2006
2006
Trends in the use of oral antidiabetic drugs by outpatients in Taiwan: 1997–2003
Chi‐Wen Chiang
,
H. Chiu
,
C.-Y. Chen
,
H‐L. Wu
,
C.-Y. Yang
Journal of Clinical Pharmacy and Therapeutics
2006
Corpus ID: 1655018
Objective: To define the prescribing patterns of oral antidiabetic drugs (OADs) in Taiwan over a 7‐year period (1997–2003) and…
Expand
Review
2005
Review
2005
Efficacy of biphasic insulin aspart in patients with type 2 diabetes.
S. Halimi
,
P. Raskin
,
A. Liebl
,
R. Kawamori
,
G. Fulcher
,
G. Yan
Clinical Therapeutics
2005
Corpus ID: 3354561
Review
2002
Review
2002
The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents.
C. Rosak
Journal of diabetes and its complications
2002
Corpus ID: 20709970
Review
2001
Review
2001
Postoperative management of the diabetic patient.
B. Hoogwerf
The Medical clinics of North America
2001
Corpus ID: 41997674
1998
1998
Pancreatic islet responsiveness to D-glucose after repeated administration of repaglinide.
A. Laghmich
,
L. Ladrière
,
F. Malaisse‐Lagae
,
W. Malaisse
European Journal of Pharmacology
1998
Corpus ID: 44943130
1996
1996
Sulphonylureas do not increase insulin secretion by a mechanism other than a rise in cytoplasmic Ca2+ in pancreatic B-cells.
M. García-Barrado
,
J. Jonas
,
P. Gilon
,
J. Henquin
European Journal of Pharmacology
1996
Corpus ID: 31691215
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE